Twist Bioscience Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US90184D1000
USD
32.81
3.11 (10.47%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Sep'18
Net Sales
312.97
245.11
203.56
132.33
90.10
54.38
25.43
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
312.97
245.11
203.56
132.33
90.10
54.38
25.43
Raw Material Cost
179.62
155.38
119.33
80.62
61.41
47.43
32.19
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.03
0.01
0.08
0.37
0.79
1.29
1.31
Selling and Distribution Expenses
218.40
189.74
212.95
135.90
103.27
80.13
43.45
Other Expenses
9.08
10.69
12.02
6.87
4.22
3.44
1.90
Total Expenditure (Excl Depreciation)
488.88
452.01
452.59
285.59
207.68
163.24
95.99
Operating Profit (PBDIT) excl Other Income
-175.9
-206.9
-249
-153.3
-117.6
-108.9
-70.6
Other Income
12.69
13.70
6.58
-0.94
1.32
2.77
0.89
Operating Profit (PBDIT)
-131.78
-163.89
-205.80
-142.20
-109.59
-99.77
-63.94
Interest
0.03
0.01
0.08
0.37
0.79
1.29
1.31
Exceptional Items
-44.93
-10.26
14.24
0.53
-22.50
0.00
-0.01
Gross Profit (PBDT)
133.35
89.73
84.23
51.71
28.69
6.96
-6.76
Depreciation
31.43
29.31
36.64
11.99
6.68
6.31
5.73
Profit Before Tax
-208.17
-203.47
-228.27
-154.03
-139.55
-107.38
-70.99
Tax
0.56
1.15
-10.41
-1.93
0.38
0.29
0.24
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-208.73
-204.62
-217.86
-152.10
-139.93
-107.67
-71.24
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-208.73
-204.62
-217.86
-152.10
-139.93
-107.67
-71.24
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-208.73
-204.62
-217.86
-152.10
-139.93
-107.67
-71.24
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
472.69
623.43
789.38
580.82
336.26
152.08
-201.42
Earnings per share (EPS)
-3.6
-3.6
-4.04
-3.15
-3.57
-3.92
-2.68
Diluted Earnings per share
-3.6
-3.6
-4.04
-3.15
-3.57
-3.92
-2.68
Operating Profit Margin (Excl OI)
-56.2%
-84.41%
-122.33%
-115.81%
-130.5%
-200.15%
-277.5%
Gross Profit Margin
-56.47%
-71.05%
-94.14%
-107.33%
-147.47%
-185.83%
-256.68%
PAT Margin
-66.69%
-83.48%
-107.02%
-114.94%
-155.31%
-197.98%
-280.16%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Sep 2024 is 27.70% vs 20.38% in Sep 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Sep 2024 is -2.00% vs 6.10% in Sep 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Sep 2024 is 18.64% vs 16.38% in Sep 2023

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Sep 2024 has improved from Sep 2023

Compare Annual Results Of Twist Bioscience Corp. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
312.97
614.38
-301.41
-49.06%
Other Operating Income
0.00
0.00
0.00
Total Operating income
312.97
614.38
-301.41
-49.06%
Raw Material Cost
179.62
317.94
-138.32
-43.51%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.03
33.63
-33.60
-99.91%
Selling and Distribution Expenses
218.40
249.64
-31.24
-12.51%
Other Expenses
9.08
1.10
7.98
725.45%
Total Expenditure (Excl Depreciation)
488.88
612.16
-123.28
-20.14%
Operating Profit (PBDIT) excl Other Income
-175.90
2.22
-178.12
-8,023.42%
Other Income
12.69
17.34
-4.65
-26.82%
Operating Profit (PBDIT)
-131.78
87.29
-219.07
-250.97%
Interest
0.03
33.63
-33.60
-99.91%
Exceptional Items
-44.93
-8.14
-36.79
-451.97%
Gross Profit (PBDT)
133.35
296.44
-163.09
-55.02%
Depreciation
31.43
67.73
-36.30
-53.60%
Profit Before Tax
-208.17
-22.21
-185.96
-837.28%
Tax
0.56
-3.69
4.25
115.18%
Provisions and contingencies
0
0
0.00
Profit After Tax
-208.73
-18.52
-190.21
-1,027.05%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-208.73
-18.52
-190.21
-1,027.05%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-208.73
-18.52
-190.21
-1,027.05%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
472.69
403.68
69.01
17.10%
Earnings per share (EPS)
-3.60
-1.04
-2.56
-246.15%
Diluted Earnings per share
-3.60
-1.04
-2.56
-246.15%
Operating Profit Margin (Excl OI)
-56.20%
0.36%
0.00
-56.56%
Gross Profit Margin
-56.47%
7.41%
0.00
-63.88%
PAT Margin
-66.69%
-3.01%
0.00
-63.68%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 31.30 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is 27.70% vs 20.38% in Sep 2023

Annual - Consolidate Net Profit
Consolidate Net Profit -20.87 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is -2.00% vs 6.10% in Sep 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -14.45 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is 18.64% vs 16.38% in Sep 2023

Annual - Interest
Markets Mojo
No Interest in the last few periods
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -56.20%
in Sep 2024

Figures in %
stock-summary

YoY Growth in year ended Sep 2024 has improved from Sep 2023